GPS Wealth Strategies Group LLC Sells 182 Shares of Zoetis Inc. (NYSE:ZTS)

GPS Wealth Strategies Group LLC decreased its position in shares of Zoetis Inc. (NYSE:ZTS) by 27.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 489 shares of the company’s stock after selling 182 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Zoetis were worth $85,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Zoetis in the 4th quarter valued at $980,646,000. Price T Rowe Associates Inc. MD grew its stake in Zoetis by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after acquiring an additional 3,244,074 shares during the period. Swedbank AB bought a new stake in shares of Zoetis in the first quarter worth about $210,815,000. Public Employees Retirement Association of Colorado acquired a new stake in shares of Zoetis during the fourth quarter worth about $242,757,000. Finally, CIBC Private Wealth Group LLC lifted its holdings in shares of Zoetis by 122.6% during the 4th quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock valued at $285,923,000 after purchasing an additional 797,884 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ZTS. Piper Sandler increased their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday. BTIG Research increased their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday. Stifel Nicolaus boosted their price objective on shares of Zoetis from $180.00 to $200.00 and gave the company a “buy” rating in a research report on Monday, August 5th. Argus upgraded Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Finally, HSBC dropped their price target on Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Nine equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $217.11.

Zoetis Stock Down 2.7 %

Shares of NYSE:ZTS traded down $5.00 during midday trading on Wednesday, reaching $183.38. The company had a trading volume of 2,122,145 shares, compared to its average volume of 2,772,392. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The stock has a market cap of $83.68 billion, a PE ratio of 35.33, a P/E/G ratio of 2.84 and a beta of 0.86. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The business’s 50 day moving average price is $177.34 and its 200 day moving average price is $175.26.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The company had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. During the same quarter in the prior year, the business posted $1.41 EPS. The business’s revenue was up 8.3% compared to the same quarter last year. Research analysts forecast that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Stockholders of record on Thursday, July 18th will be given a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date is Thursday, July 18th. Zoetis’s dividend payout ratio (DPR) is presently 33.14%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.